Exploring efficacy and safety of oral Pirfenidone for progressive, non-IPF lung fibrosis (RELIEF) - a randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial
Pre-publication versions of this article are available by contacting email@example.com.
|30 Dec 2016||Submitted||Original manuscript|
|5 Feb 2017||Author responded||Author comments - Juergen Behr|
|Resubmission - Version 2|
|5 Feb 2017||Submitted||Manuscript version 2|
|21 Mar 2017||Reviewed||Reviewer Report - Rade Tomic|
|1 Apr 2017||Reviewed||Reviewer Report - Giovanni Ferrara|
|4 May 2017||Author responded||Author comments - Juergen Behr|
|Resubmission - Version 3|
|4 May 2017||Submitted||Manuscript version 3|
|11 Aug 2017||Reviewed||Reviewer Report - Rade Tomic|
|Resubmission - Version 4|
|Submitted||Manuscript version 4|
|23 Aug 2017||Editorially accepted|
|6 Sep 2017||Article published||10.1186/s12890-017-0462-y|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.